drugset / Trial / NCT05495711

hUC Mesenchymal Stem Cells (19#iSCLife®-UT) Therapy for Patients With Thin Endometrial Infertility

NCT05495711 ↗

Phase 1 Completed 25 enrolled Sclnow Biotechnology Co., Ltd.
RandomizedParallel-groupDouble-blindTreatment

Summary

To explore the therapeutic effect and safety of human umbilical cord mesenchymal stem cells on thin endometrial infertility and to explore whether human umbilical cord mesenchymal stem cells using collagen as the carrier can promote endometrial growth, reduce the recurrence rate of intrauterine adhesion, increase the clinical pregnancy rate, improve the pregnancy outcome, and study its safety.

Timeline

Start
2022-08-01
Primary completion
2023-06-01
Completion
2023-11-01

Drugs

EvaluationDrugModalityDoseRoute
Subject 19#iSCLife®-UT Cell therapy 1e+07 cells Other

Indications